Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase
Hepatitis C virus (HCV) is an important etiological agent of severe liver diseases, including cirrhosis and hepatocellular carcinoma. The HCV genome encodes nonstructural protein 3 (NS3) helicase, which is a potential anti-HCV drug target because its enzymatic activity is essential for viral replica...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/8/18439 |
id |
doaj-335ad083a37c4296872a1cb1855a34d0 |
---|---|
record_format |
Article |
spelling |
doaj-335ad083a37c4296872a1cb1855a34d02020-11-25T01:30:49ZengMDPI AGInternational Journal of Molecular Sciences1422-00672015-08-01168184391845310.3390/ijms160818439ijms160818439Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 HelicaseAtsushi Furuta0Masayoshi Tsubuki1Miduki Endoh2Tatsuki Miyamoto3Junichi Tanaka4Kazi Abdus Salam5Nobuyoshi Akimitsu6Hidenori Tani7Atsuya Yamashita8Kohji Moriishi9Masamichi Nakakoshi10Yuji Sekiguchi11Satoshi Tsuneda12Naohiro Noda13Department of Life Science and Medical Bioscience, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, JapanInstitute of Medical Chemistry, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, JapanInstitute of Medical Chemistry, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, JapanDepartment of Life Science and Medical Bioscience, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, JapanDepartment of Chemistry, Biology and Marine Science, University of the Ryukyus, Nishihara, Okinawa 903-0213, JapanRadioisotope Center, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo 113-0032, JapanRadioisotope Center, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo 113-0032, JapanEnvironmental Measurement Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, JapanDepartment of Microbiology, Division of Medicine, Graduate School of Medicine and Engineering, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, JapanDepartment of Microbiology, Division of Medicine, Graduate School of Medicine and Engineering, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, JapanDepartment of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi-shi, Chiba 274-8510, JapanBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, JapanDepartment of Life Science and Medical Bioscience, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, JapanDepartment of Life Science and Medical Bioscience, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, JapanHepatitis C virus (HCV) is an important etiological agent of severe liver diseases, including cirrhosis and hepatocellular carcinoma. The HCV genome encodes nonstructural protein 3 (NS3) helicase, which is a potential anti-HCV drug target because its enzymatic activity is essential for viral replication. Some anthracyclines are known to be NS3 helicase inhibitors and have a hydroxyanthraquinone moiety in their structures; mitoxantrone, a hydroxyanthraquinone analogue, is also known to inhibit NS3 helicase. Therefore, we hypothesized that the hydroxyanthraquinone moiety alone could also inhibit NS3 helicase. Here, we performed a structure–activity relationship study on a series of hydroxyanthraquinones by using a fluorescence-based helicase assay. Hydroxyanthraquinones inhibited NS3 helicase with IC50 values in the micromolar range. The inhibitory activity varied depending on the number and position of the phenolic hydroxyl groups, and among different hydroxyanthraquinones examined, 1,4,5,8-tetrahydroxyanthraquinone strongly inhibited NS3 helicase with an IC50 value of 6 µM. Furthermore, hypericin and sennidin A, which both have two hydroxyanthraquinone-like moieties, were found to exert even stronger inhibition with IC50 values of 3 and 0.8 µM, respectively. These results indicate that the hydroxyanthraquinone moiety can inhibit NS3 helicase and suggest that several key chemical structures are important for the inhibition.http://www.mdpi.com/1422-0067/16/8/18439hepatitis C virusNS3 helicasefluorescence resonance energy transferinhibitorhydroxyanthraquinonehypericinsennidin A |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Atsushi Furuta Masayoshi Tsubuki Miduki Endoh Tatsuki Miyamoto Junichi Tanaka Kazi Abdus Salam Nobuyoshi Akimitsu Hidenori Tani Atsuya Yamashita Kohji Moriishi Masamichi Nakakoshi Yuji Sekiguchi Satoshi Tsuneda Naohiro Noda |
spellingShingle |
Atsushi Furuta Masayoshi Tsubuki Miduki Endoh Tatsuki Miyamoto Junichi Tanaka Kazi Abdus Salam Nobuyoshi Akimitsu Hidenori Tani Atsuya Yamashita Kohji Moriishi Masamichi Nakakoshi Yuji Sekiguchi Satoshi Tsuneda Naohiro Noda Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase International Journal of Molecular Sciences hepatitis C virus NS3 helicase fluorescence resonance energy transfer inhibitor hydroxyanthraquinone hypericin sennidin A |
author_facet |
Atsushi Furuta Masayoshi Tsubuki Miduki Endoh Tatsuki Miyamoto Junichi Tanaka Kazi Abdus Salam Nobuyoshi Akimitsu Hidenori Tani Atsuya Yamashita Kohji Moriishi Masamichi Nakakoshi Yuji Sekiguchi Satoshi Tsuneda Naohiro Noda |
author_sort |
Atsushi Furuta |
title |
Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase |
title_short |
Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase |
title_full |
Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase |
title_fullStr |
Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase |
title_full_unstemmed |
Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase |
title_sort |
identification of hydroxyanthraquinones as novel inhibitors of hepatitis c virus ns3 helicase |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2015-08-01 |
description |
Hepatitis C virus (HCV) is an important etiological agent of severe liver diseases, including cirrhosis and hepatocellular carcinoma. The HCV genome encodes nonstructural protein 3 (NS3) helicase, which is a potential anti-HCV drug target because its enzymatic activity is essential for viral replication. Some anthracyclines are known to be NS3 helicase inhibitors and have a hydroxyanthraquinone moiety in their structures; mitoxantrone, a hydroxyanthraquinone analogue, is also known to inhibit NS3 helicase. Therefore, we hypothesized that the hydroxyanthraquinone moiety alone could also inhibit NS3 helicase. Here, we performed a structure–activity relationship study on a series of hydroxyanthraquinones by using a fluorescence-based helicase assay. Hydroxyanthraquinones inhibited NS3 helicase with IC50 values in the micromolar range. The inhibitory activity varied depending on the number and position of the phenolic hydroxyl groups, and among different hydroxyanthraquinones examined, 1,4,5,8-tetrahydroxyanthraquinone strongly inhibited NS3 helicase with an IC50 value of 6 µM. Furthermore, hypericin and sennidin A, which both have two hydroxyanthraquinone-like moieties, were found to exert even stronger inhibition with IC50 values of 3 and 0.8 µM, respectively. These results indicate that the hydroxyanthraquinone moiety can inhibit NS3 helicase and suggest that several key chemical structures are important for the inhibition. |
topic |
hepatitis C virus NS3 helicase fluorescence resonance energy transfer inhibitor hydroxyanthraquinone hypericin sennidin A |
url |
http://www.mdpi.com/1422-0067/16/8/18439 |
work_keys_str_mv |
AT atsushifuruta identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase AT masayoshitsubuki identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase AT midukiendoh identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase AT tatsukimiyamoto identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase AT junichitanaka identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase AT kaziabdussalam identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase AT nobuyoshiakimitsu identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase AT hidenoritani identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase AT atsuyayamashita identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase AT kohjimoriishi identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase AT masamichinakakoshi identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase AT yujisekiguchi identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase AT satoshitsuneda identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase AT naohironoda identificationofhydroxyanthraquinonesasnovelinhibitorsofhepatitiscvirusns3helicase |
_version_ |
1725089609558261760 |